Welcome to Avanir Clinical Trials

Pain Research in Multiple Sclerosis (MS)

Who can enroll in the study?

  • Diagnosed with MS
  • Suffering from nerve (neuropathic) pain (e.g. burning, pricking, numbness)
  • Are between the ages of 18-85
  • Qualified volunteers may receive study related medical evaluations and study drug at no cost
  • No cost for study participation
Agitation in Alzheimer’s Disease (AD)

Who can enroll in the study?

  • Diagnosed with Alzheimer's Disease (AD)
  • Have symptoms of irritability, agitation, aggression or anger that are disruptive of the daily routine
  • Are between the ages of 50-90
  • Have a caregiver available for study participation
  • Have stable health
  • No cost for study participation
Pseudobulbar affect Registry Investigating Symptom Management

Who can enroll in the study?

  • PRISM II is a 12 week long study testing the safety and effectiveness of NUEDEXTA (dextromethorphan HBr and quinidine sulfate) Capsules, 20mg/10mg in the treatment of pseudobulbar affect (PBA) in post stroke, dementia and traumatic brain injury (TBI) patients.
NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate) 20mg/10mg capsules can interact with other medications and cause serious side effects. NUEDEXTA is contraindicated in patients taking certain drugs and in patients with specific cardiovascular risk factors. These are not all the risks from use of NUEDEXTA. Please see the Important Safety Information and full Prescribing Information
PRIME
AGITATION in AD
PRISM II